Lead is a potent poison that affects multiple body systems. It is well documented that children under age 6 years and the fetus are especially vulnerable to neurologic damage affecting learning and behavior with potential for life-long impact. In 1991, the Centers for Disease Control and Prevention (CDC) lowered the blood lead level (BLL) of concern for children from 25 to 10 micrograms per deciliter (μg/dL) (CDC 1991).1 Efforts to reduce lead in the environment, primarily by eliminating lead from gasoline and paint, have resulted in lowering the overall geometric mean BLL for the general population in the United States from approximately 13 micrograms per deciliter (μg/dL) in the late 1970’s to <2 μg/dL by 1999 (NCHS 1984; CDC 2001).2,3 Although the average BLL has markedly declined, National Health and Nutrition Examination Survey (NHANES) 1999– 2000 data indicate that 2.2% of U.S. children aged 1 to 5 years had BLLs ≥10 μg/dL (CDC 2003).4 Recent research suggests that levels once thought safe are considered hazardous as new information emerges about lead’s harmful effects at BLLs less than 10 μg/dL.5,6 Despite success in reducing the number of children with elevated BLLs, some remain at high risk for lead exposure, including those living in homes containing lead-contaminated dust. Invisible toxins may be carried home to household members by inadequately protected workers on their clothes, shoes, or bodies, called “take-home exposure.” Documented cases of take-home exposure include lead, beryllium, asbestos, pesticides, and other toxic materials.7 In this case series, we describe take-home lead exposure incidents in California from 1992 to 2002. Lead is used in more than 100 industries. Lead dust carried from work settles on surfaces in the vehicle and home where it can be ingested or inhaled by young children with normal mouthing behavior and by household members handling workers’ clothing. Children of lead-exposed workers have disproportionately high BLLs when compared to other children.8-10 One study estimated that 48,000 families have children under age 6 living with household members occupationally exposed to lead.11 Reports of take-home lead exposure include work in mining,8,12 automotive radiator repair,13 battery reclamation,14 construction,9 and antique furniture refinishing.15
Elevated blood lead levels (BLLs) in adults can damage the cardiovascular, central nervous, reproductive, hematologic, and renal systems. The majority of cases are workplace-related. U.S. Department of Health and Human Services recommends that BLLs among all adults be reduced to < 25 microg/dL. The highest BLL acceptable by standards of the U.S. Occupational Safety and Health Administration is 40 microg/dL. The mean BLL of adults in the United States is < 3 microg/dL.This report covers cases of adults (aged > or = 16 years) with BLLs > or = 25 microg/dL, as reported by 25 states during 1998-2001.Since 1987, CDC has sponsored the state-based Adult Blood Lead Epidemiology and Surveillance (ABLES) program to track cases of elevated BLLs and provide intervention consultation and other assistance. Overall ABLES program data were last published in 1999 for the years 1994-1997. This report provides an update with data from 25 states reporting for > or = 2 years during 1998-2001. During that period, the ABLES program funded surveillance in 21 states - Alabama, Arizona, Connecticut, Iowa, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Washington, Wisconsin, and Wyoming. Four additional states - California, Nebraska, New Hampshire, and Utah contributed data without CDC funding.During 1998-2001, the overall program's annual mean state prevalence rate for adults with BLLs > or = 25 microg/dL was 13.4/100,000 employed adults. This compares with 15.2/100,000 for 1994-1997. Yearly rates were 13.8 (1998), 12.9 (1999), 14.3 (2000), and 12.5 (2001). For adults with BLLs > or = 40 microg/dL, the overall program's annual mean state prevalence rare during 1998-2001 was 2.9/ 100,000 employed adults. This compares with 3.9/100,000 for 1994-1997. Yearly rates were 3.3 (1998), 2.5 (1999), 2.9 (2000), and 2.8 (2001).Although certain limitations exist, the overall ABLES data indicate a declining trend in elevated BLLs among employed adults.ABLES-funded states increased from 21 to 35 in 2002, and more detailed reporting requirements were put into effect. These, and other improvements, will enable the ABLES program to work more effectively toward its 2010 target of eliminating all cases of BLLs > or = 25 microg/dL in adults caused by workplace exposures.
To evaluate the epidemiology of HIV infection in Asian and Pacific Islander populations in San Francisco, we compared cases of AIDS reported in Asians and Pacific Islanders with those reported in other racial and ethnic groups. The incidence of AIDS in Asians and Pacific Islanders was significantly lower than in Whites, Blacks, Latinos and American Indians and Alaska natives. AIDS cases among Asians and Pacific Islanders have increased 177% since 1985 compared with 54% in other racial and ethnic groups, with the greatest increase in homosexual and bisexual men and transfusion recipients. Among Asian and Pacific Islander ethnic groups, the incidence of AIDS was 168 cases per 100,000 in Polynesians, 141 per 100,000 in Japanese, 92 per 100,000 in 100 Filipinos, 72 per 100,000 in southeast Asians, and 21 per 100,000 in Chinese. We conclude that AIDS cases are disproportionately increasing in Asians and Pacific Islanders in San Francisco.In Asia and in people of Asian and Pacific Islander ancestry in the United States, AIDS is a rare disease. San Francisco, with the highest incidence of AIDS in the United States, also has the highest percentage (21%) of Asians and Pacific Islanders. To understand the potential for AIDS in this select population, trends over time and the demographics of reported AIDS cases among the select population in San Francisco were analyzed. Records were reviewed of AIDS cases reported to the San Francisco Department of Health, which had a substantiated 98% report rate. As of March 31,1988, 83 (1.8%) of the 4689 cases and 42 (1.5%) of the 2831 deaths reported were among the select population. The incidence of AIDS among the select population (58.5/100,000) was significantly lower than among whites (1108.8/100,000), blacks (368.9/100,000), and latinos (421.0/100,000). Among the select population, however, AIDS increased more rapidly since 1985 than among the whites, blacks, or latinos. Of the 83 cases reported, 69 were homosexual or bisexual men without intravenous drug use, 3 homosexual or bisexual men with histories of intravenous drug use, 6 were transfusion recipients, 3 were heterosexual intravenous drug users, 1 was a heterosexual contact of a person at risk for AIDS, and 1 was a hemophiliac. Comparison of transmission categories of the select population with those of the other racial and ethnic groups showed a significantly greater (P 0.001) number of transfusion recipients and a significantly lower (P 0.02) number of homosexual and bisexual intravenous drug users. The greatest increase in cases among the select population was in homosexual and bisexual men without histories of intravenous drug use, which was greater than the increase among nonAsian or Pacific Islander homosexual and bisexual men (P 0.10). These findings support the theory that HIV entered the select population communities later than it did nonAsian or Pacific Islander communities.
To evaluate survival for AIDS patients diagnosed with Kaposi's sarcoma (KS), we calculated survival for 1,015 patients reported in San Francisco between July 1981 and December 31, 1987, representing 22% of total patients reported. These patients had a definitive initial diagnosis of KS, and developed no other diseases within 3 months of diagnosis. Patients were followed prospectively through December 31, 1988. All patients evaluated in this study were men. Survival was evaluated for subgroups based on age, race and ethnicity, year of diagnosis, and transmission category. The median survival for patients diagnosed with KS alone was 17.0 months, with a 5-year survival rate of 8.7%. Poorer prognosis was found for patients with older age at diagnosis and with later year of diagnosis. Proportional hazards analysis indicated that age (p less than 0.001) and year of diagnosis (p less than 0.05) were significant independent predictors of survival, while race or ethnicity and risk group were not.
To examine the effect of the revision of the US national AIDS case definition in September 1987, we compared demographic and clinical information for AIDS patients diagnosed and reported to the San Francisco Department of Public Health between 1 September 1987 and 31 October 1989. Of the 3167 patients diagnosed and reported during the study period, 584 (18%) met the revised case definition only, increasing AIDS case reporting in San Francisco by 23%. One hundred and thirty-four of these 584 patients (23%) subsequently developed diagnoses meeting the old definition. After adjusting for this proportion, the revised case definition increased reporting by 17%. The mean time between initial diagnosis with a disease meeting the revised definition and subsequent development of a disease meeting the old definition was 18.5 months. Patients who met the revised case definition only were slightly older and more likely to be Black, female, and intravenous drug users (IVDUs) than those meeting the old case definition. The majority of patients who met the revised case definition only had initial diagnoses of HIV wasting syndrome (26%), HIV encephalopathy (21%), and presumptive Pneumocystis carinii pneumonia (19%). The revised AIDS case definition has significantly increased the reporting of severe morbidity associated with HIV infection, particularly among IVDUs.
CDC's National Institute for Occupational Safety and Health (NIOSH) and state health departments collect data on laboratory-reported adult blood lead levels (BLLs). This report presents data on elevated BLLs among employed adults (defined as persons aged ≥16 years) in the United States for 1994-2013. This report is a part of the Summary of Notifiable Noninfectious Conditions and Disease Outbreaks - United States, which encompasses various surveillance years but is being published in 2016 (1). The Summary of Notifiable Noninfectious Conditions and Disease Outbreaks appears in the same volume of the Morbidity Mortality Weekly Report (MMWR) as the annual Summary of Notifiable Infectious Diseases (2).
Abstract Background Residential and commercial painters disturb lead paint on older buildings, exposing workers and potentially building occupants. An intervention strategy was evaluated for improving lead safety in these small businesses. Methods Twenty‐one painting contractors received 32 hr of training, technical assistance, and a safety manual; their employees attended an 8‐hr training session. Impact evaluation involved interviewing participants at baseline, immediately post‐intervention, and 1 year later, and conducting contractor focus groups post‐intervention. Results Employers met 15 of 27 target objectives and workers met 3 of 12; however, even in areas where objectives were not met, both groups made improvements. Conclusions Motivated contractors and their employees can make moderate improvements in lead‐safe practices if provided with extensive training and technical assistance. Changes that are costly, unfamiliar, or perceived as a threat to work quality are more difficult to implement. Am. J. Ind. Med. 41:119–130, 2002. Published 2002 Wiley‐Liss, Inc.
To develop a model for predicting acquired immunodeficiency syndrome (AIDS) morbidity in San Francisco, Calif, through June 1993, we combined annual human immunodeficiency virus seroconversion rates for homosexual and bisexual men and for heterosexual intravenous drug users with estimates of the cumulative proportion of the population with AIDS by duration of human immunodeficiency virus infection and with estimates of the size of the at-risk populations. We projected AIDS mortality by applying Kaplan-Meier estimates of survival time following diagnosis to the projected number of cases. The median incubation period for AIDS among homosexual and bisexual men infected with the human immunodeficiency virus was estimated to be 11.0 years (mean, 11.8 years; 95% confidence interval, 10.6 to 13.0 years). The model projects 12,349 to 17,022 cumulative cases of AIDS in San Francisco through June 1993, with 9,966 to 12,767 cumulative deaths.
